Cargando…

Prevalence of Australians exposed to potentially cardiotoxic cancer medicines: a population-based cohort study

BACKGROUND: Cardiovascular disease (CVD) and cancer are leading causes of death and people with cancer are at higher risk of developing CVD than the general population. Many cancer medicines have cardiotoxic effects but the size of the population exposed to these potentially cardiotoxic medicines is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daniels, Benjamin, Aslam, Maria, van Leeuwen, Marina T., Brown, Martin, Hunt, Lee, Gurney, Howard, Tang, Monica, Pearson, Sallie-Anne, Vajdic, Claire M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410507/ https://www.ncbi.nlm.nih.gov/pubmed/37565067 http://dx.doi.org/10.1016/j.lanwpc.2023.100872

Ejemplares similares

Incidence and risk factors of hypertension therapy in Australian cancer patients treated with vascular signalling pathway inhibitors
por: Hong, Soojung, et al.
Publicado: (2022)

Cardiovascular toxicity of targeted therapies for cancer: a protocol for an overview of systematic reviews
por: van Leeuwen, Marina T, et al.
Publicado: (2018)

Cardiovascular Toxicity of Targeted Therapies for Cancer: An Overview of Systematic Reviews
por: Van Leeuwen, Marina T, et al.
Publicado: (2020)

The Medicines Intelligence Centre of Research Excellence: Co-creating real-world evidence to support the evidentiary needs of Australian medicines regulators and payers
por: Pratt, Nicole, et al.
Publicado: (2022)

Trastuzumab use in older patients with HER2-positive metastatic breast cancer: outcomes and treatment patterns in a whole-of-population Australian cohort (2003–2015)
por: Daniels, Benjamin, et al.
Publicado: (2019)

Dispensing Practices of Fixed Dose Combination Controller Therapy for Asthma in Australian Children and Adolescents
por: Homaira, Nusrat, et al.
Publicado: (2020)

Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study
por: Tang, Monica, et al.
Publicado: (2021)

Trastuzumab emtansine for HER2-positive metastatic breast cancer: Outcomes from a whole-of-population Australian cohort
por: Daniels, Benjamin, et al.
Publicado: (2021)

Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016)
por: Tang, Monica, et al.
Publicado: (2019)

Correction: Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016)
por: Tang, Monica, et al.
Publicado: (2020)

Opportunities for post-market surveillance of high cost medicines in Australia: Observing trastuzumab-treated women from early through late stage HER2-positive breast cancer (HER2BC)
por: Daniels, Benjamin, et al.
Publicado: (2017)

The use and impact of cancer medicines in routine clinical care: methods and observations in a cohort of elderly Australians
por: Pearson, Sallie-Anne, et al.
Publicado: (2014)

Effectiveness of COVID-19 vaccination against COVID-19 specific and all-cause mortality in older Australians: a population based study
por: Liu, Bette, et al.
Publicado: (2023)

The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers
por: Mellish, Leigh, et al.
Publicado: (2015)

Diagnostic and health service pathways to diagnosis of cancer-registry notified cancer of unknown primary site (CUP)
por: Schaffer, Andrea L., et al.
Publicado: (2020)

Low-value care in Australian public hospitals: prevalence and trends over time
por: Badgery-Parker, Tim, et al.
Publicado: (2019)

Animal Models in Studies of Cardiotoxicity Side Effects from Antiblastic Drugs in Patients and Occupational Exposed Workers
por: Lamberti, Monica, et al.
Publicado: (2014)

Cardiotoxicity: precision medicine with imprecise definitions
por: Chung, Robin, et al.
Publicado: (2018)

Cardiotoxicity and Chemotherapy—The Role of Precision Medicine
por: Viswanathan, Thyla, et al.
Publicado: (2021)

Prescribed medicine use and extent of off‐label use according to age in a nationwide sample of Australian children
por: Schaffer, Andrea L., et al.
Publicado: (2022)

Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
por: Volkova, Maria, et al.
Publicado: (2011)

Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: a national population-based observational study (2006–2014)
por: Daniels, Benjamin, et al.
Publicado: (2018)

Comparison of claims from high–drug cost beneficiaries in Ontario, Canada, and Australia: a cross-sectional analysis
por: Tadrous, Mina, et al.
Publicado: (2021)

Living with COVID-19 and cancer: the need for observational research in the post-pandemic world
por: Daniels, Benjamin, et al.
Publicado: (2023)

Prevalence and incidence of physical health conditions in people with intellectual disability – a systematic review
por: Liao, Peiwen, et al.
Publicado: (2021)

The changing face of Australian data reforms: impact on pharmacoepidemiology research
por: de Oliveira Costa, Juliana, et al.
Publicado: (2021)

Aging, cardiotoxicity, and chemotherapy
por: Bocchi, Edimar Alcides, et al.
Publicado: (2019)

Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013–2016
por: Daniels, Benjamin, et al.
Publicado: (2020)

An International Survey of Health Care Providers Involved in the Management of Cancer Patients Exposed to Cardiotoxic Therapy
por: Sulpher, Jeffrey, et al.
Publicado: (2015)

Generating Real-World Evidence on the Quality Use, Benefits and Safety of Medicines in Australia: History, Challenges and a Roadmap for the Future
por: Pearson, Sallie-Anne, et al.
Publicado: (2021)

Electronic information and clinical decision support for prescribing: state of play in Australian general practice
por: Robertson, Jane, et al.
Publicado: (2011)

Age-stratified outcomes of bioprosthetic and mechanical aortic valve replacements in an Australian cohort of 13 377 patients
por: Sotade, Oluwadamisola Temilade, et al.
Publicado: (2020)

Evaluating the accuracy of data extracted from electronic health records into MedicineInsight, a national Australian general practice database
por: Daniels, Benjamin, et al.
Publicado: (2022)

Validity of algorithms for identifying five chronic conditions in MedicineInsight, an Australian national general practice database
por: Havard, Alys, et al.
Publicado: (2021)

Health care use and costs at the end of life: a comparison of elderly Australian decedents with and without a cancer history
por: Reeve, Rebecca, et al.
Publicado: (2017)

Agreement of acute serious events recorded across datasets using linked Australian general practice, hospital, emergency department and death data: implications for research and surveillance
por: Ahmed, Sarah, et al.
Publicado: (2023)

Patterns of immediate breast reconstruction in New South Wales, Australia: a population‐based study
por: Feng, Yingyu, et al.
Publicado: (2019)

Socio-demographic and health service factors associated with antibiotic dispensing in older Australian adults
por: Chen, Yingxi, et al.
Publicado: (2019)

Rates of Low-Value Service in Australian Public Hospitals and the Association With Patient Insurance Status
por: de Oliveira Costa, Juliana, et al.
Publicado: (2021)

Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia
por: Bruno, Claudia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_10hsqeb85ec82jmsiogcgkvlov